Propolis suppresses atopic dermatitis through targeting the MKK4 pathway
Authors:
Open Access
- 20 August 2024
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 51 (1)
Abstract
Propolis is a natural resinous substance made by bees through mixing various plant sources. Propolis has been widely recognized as a functional food due to its diverse range of beneficial bioactivities. However, the therapeutic effects of consuming propolis against atopic dermatitis (AD) remain largely unknown. The current study aimed to investigate the potential efficacy of propolis against AD and explore the active compound as well as the direct molecular target. In HaCaT keratinocytes, propolis inhibited TNF‐α‐induced interleukin (IL)‐6 and IL‐8 secretion. It also led to a reduction in chemokines such as monocyte chemoattractant protein‐1 (MCP‐1) and macrophage‐derived chemokine (MDC), while restoring the levels of barrier proteins, filaggrin and involucrin. Propolis exhibited similar effects in AD‐like human skin, leading to the suppression of AD markers and the restoration of barrier proteins. In DNCB‐induced mice, oral administration of propolis attenuated AD symptoms, improved barrier function, and reduced scratching frequency and transepidermal water loss (TEWL). In addition, propolis reversed the mRNA levels of AD‐related markers in mouse dorsal skin. These effects were attributed to caffeic acid phenethyl ester (CAPE), the active compound identified by comparing major components of propolis. Mechanistic studies revealed that CAPE as well as propolis could directly and selectively target MKK4. Collectively, these findings demonstrate that propolis may be used as a functional food agent for the treatment of AD.Keywords
Funding Information
- National Research Foundation of Korea (RS‐2023‐00222838)
- Rural Development Administration (PJ01627704)
This publication has 59 references indexed in Scilit:
- Caffeic acid phenethyl ester inhibits MDA-MB-231 cell proliferation in inflammatory microenvironment by suppressing glycolysis and lipid metabolismBiomedicine & Pharmacotherapy, 2023
- Combination of UHPLC-MS/MS with context-specific network and cheminformatic approaches for identifying bioactivities and active components of propolisFood Research International, 2023
- Phenolic changes in a combined herbal extract of Lithospermum erythrorhizon, Houttuynia cordata, and Spirodela polyrhiza and alleviation of DNCB-induced atopic dermatitis in BALB/c miceFood Science and Biotechnology, 2023
- Propolis: chemical diversity and challenges in quality controlPhytochemistry Reviews, 2022
- Prevention and management of glucocorticoid-induced side effects: A comprehensive reviewJournal of the American Academy of Dermatology, 2017
- Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl esterArchives of Dermatological Research, 2014
- Suppression of interleukin 17 production by Brazilian propolis in mice with collagen-induced arthritisInflammopharmacology, 2011
- Crystal structures of MKK4 kinase domain reveal that substrate peptide binds to an allosteric site and induces an auto-inhibition stateBiochemical and Biophysical Research Communications, 2010
- Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c miceInternational Immunopharmacology, 2004
- Local lymph node activation in rats after dermal application of the sensitizers 2,4-dinitrochlorobenzene and trimellitic anhydrideFood and Chemical Toxicology, 1996